Literature DB >> 27437261

Comparison of Hypnotherapy and Standard Medical Treatment Alone on Quality of Life in Patients with Irritable Bowel Syndrome: A Randomized Control Trial.

Korosh Shahbazi1, Kamal Solati2, Ali Hasanpour-Dehkordi3.   

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) is one of the most prevalent gastroenterological disorders. IBS is characterized by abdominal pain, cramping, diarrhea, constipation, bloating and flatulence. Complementary therapy is a group of diverse therapeutic and health care systems products that are used in treatment of IBS. Hypnotherapy helps to alleviate the symptoms of a broad range of diseases and conditions. It can be used independently or along with other treatments. AIM: This study was conducted to compare therapeutic effect of hypnotherapy plus standard medical treatment and standard medical treatment alone on quality of life in patients with IBS.
MATERIALS AND METHODS: This study is a clinical trial investigating 60 patients who were enrolled according to Rome-III criteria. The sample size was determined per statistical advice, previous studies, and the formula of sample size calculation. The participants were randomly assigned to two groups of hypnotherapy plus standard medical treatment group (n: 30), and standard medical treatment group (30). The study consisted of three steps; prior to treatment, after treatment and six months after the last intervention (follow-up). The instruments of data gathering were a questionnaire of demographic characteristics and standard questionnaire of quality of life for IBS patients (Quality of Life IBS-34). The data were analysed by analysis of co-variance, Levene's test and descriptive statistics in SPSS-18.
RESULTS: There were significant differences between the two groups of study in post-treatment and follow-up stage with regards to quality of life (p<0.05).
CONCLUSION: Psychological intervention, particularly hypno-therapy, alongside standard medical therapy could contribute to improving quality of life, pain and fatigue, and psychological disorder in IBS patients resistant to treatment. Also, therapeutic costs, hospital stay and days lost from work could be decreased and patients' efficiency could be increased.

Entities:  

Keywords:  Complementary medicine; Inflammatory bowel disease(HBD); Quality of life

Year:  2016        PMID: 27437261      PMCID: PMC4948437          DOI: 10.7860/JCDR/2016/17631.7713

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  The effect of an exercise program on the health-quality of life in older adults. A randomized controlled trial.

Authors:  Saeed Heydarnejad; Ali Hassanpour Dehkordi
Journal:  Dan Med Bull       Date:  2010-01

Review 2.  Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.

Authors:  S Wilson; T Maddison; L Roberts; S Greenfield; S Singh
Journal:  Aliment Pharmacol Ther       Date:  2006-09-01       Impact factor: 8.171

3.  Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).

Authors:  Michel Amouretti; Claude Le Pen; Anne-Françoise Gaudin; Gilles Bommelaer; Jacques Frexinos; Philippe Ruszniewski; Thierry Poynard; Frédérique Maurel; Gaël Priol; Abdelkader El Hasnaoui
Journal:  Gastroenterol Clin Biol       Date:  2006-02

4.  Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.

Authors:  Gabriele Moser; Silja Trägner; Ewelina Elwira Gajowniczek; Andrea Mikulits; Maria Michalski; Lili Kazemi-Shirazi; Stefanie Kulnigg-Dabsch; Martina Führer; Elisabeth Ponocny-Seliger; Clemens Dejaco; Wolfgang Miehsler
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

Review 5.  Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  J Gastroenterol Hepatol       Date:  2010-01-13       Impact factor: 4.029

6.  A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.

Authors:  R Moss-Morris; L McAlpine; L P Didsbury; M J Spence
Journal:  Psychol Med       Date:  2009-06-17       Impact factor: 7.723

Review 7.  [Hypnotherapy for irritable bowel syndrome--a systematic review].

Authors:  J Hefner; A Rilk; B M Herbert; S Zipfel; P Enck; U Martens
Journal:  Z Gastroenterol       Date:  2009-11-06       Impact factor: 2.000

8.  Functional bowel disorders in Iranian population using Rome III criteria.

Authors:  Majid Sorouri; Mohammad A Pourhoseingholi; Mohsen Vahedi; Azadeh Safaee; Bijan Moghimi-Dehkordi; Asma Pourhoseingholi; Manijeh Habibi; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

9.  The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study.

Authors:  Sun Hyung Kang; Seong-Woo Choi; Seung Jun Lee; Woo Suk Chung; Hye Ran Lee; Ki-Young Chung; Eaum Seok Lee; Hee Seok Moon; Seok Hyun Kim; Jae Kyu Sung; Byung Seok Lee; Hyun Yong Jeong
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

10.  Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J).

Authors:  Motoyori Kanazawa; Douglas A Drossman; Masae Shinozaki; Yasuhiro Sagami; Yuka Endo; Olafur S Palsson; Michio Hongo; William E Whitehead; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2007-03-03
View more
  11 in total

1.  Effect of Sleep Hygiene Education on Sleep Quality in Hemodialysis Patients.

Authors:  Farzaneh Soleimani; Hossein Motaarefi; Ali Hasanpour-Dehkordi
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 2.  The Prevalence of Infectious Keratitis after Keratorefractive Surgery: A Systematic Review and Meta-Analysis Study.

Authors:  Shahla Afsharpaiman; Musa Zare; Masoud Yasemi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Ophthalmol       Date:  2020-07-28       Impact factor: 1.909

Review 3.  Systematic Review and Meta-analysis of Quality of Work Life in Iran (2011-2017).

Authors:  Akram Sanagoo; Diana Sarokhani; Ali Hasanpour Dehkordi; Kourosh Sayehmiri; Leila Jouybari
Journal:  Int J Prev Med       Date:  2020-07-03

4.  The Effectiveness of Mindfulness-based Cognitive Therapy on Psychological Symptoms and Quality of Life in Systemic Lupus Erythematosus Patients: 
A Randomized Controlled Trial.

Authors:  Kamal Solati; Mohammad Mousavi; Soleiman Kheiri; Ali Hasanpour-Dehkordi
Journal:  Oman Med J       Date:  2017-09

5.  Self-Perception of Iranian Patients during their life with Irritable Bowel Syndrome: A Qualitative Study.

Authors:  Zinat Mohebbi; Farkhondeh Sharif; Hamid Peyrovi; Mahnaz Rakhshan; Mahvash Alizade Naini; Ladan Zarshenas
Journal:  Electron Physician       Date:  2017-12-25

6.  Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.

Authors:  Sarah Ballou; Laurie Keefer
Journal:  Clin Transl Gastroenterol       Date:  2017-01-19       Impact factor: 4.488

7.  A Comparison of the Effects of Pilates and McKenzie Training on Pain and General Health in Men with Chronic Low Back Pain: A Randomized Trial.

Authors:  Ali Hasanpour-Dehkordi; Arman Dehghani; Kamal Solati
Journal:  Indian J Palliat Care       Date:  2017 Jan-Mar

8.  Nesfatin-1 in the dorsal raphe nucleus influences visceral sensitivity via 5-HT neurons in male maternally separated rats.

Authors:  Hui-Ai Zhang; Nan Sang; Xian Ge; Qian Huang; Xue-Liang Li; Jie Sha
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

9.  Comparing the Effect of Intranasal Lidocaine 4% with Peppermint Essential Oil Drop 1.5% on Migraine Attacks: A Double-Blind Clinical Trial.

Authors:  Mahmood Rafieian-Kopaei; Ali Hasanpour-Dehkordi; Zahra Lorigooini; Fatemeh Deris; Kamal Solati; Faezeh Mahdiyeh
Journal:  Int J Prev Med       Date:  2019-07-05

10.  The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.

Authors:  Ali Hassanpour Dehkordi; Kamal Solati
Journal:  J Adv Pharm Technol Res       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.